BNB PLUS CORP (BNBX)
NASDAQFinancialsBiotechnologySnapshot 2026-10-29
$0.14-12.50%
Close 2026-08-10 · 1-day change
NASDAQFinancialsBiotechnologySnapshot 2026-10-29
Research Workspace
Put BNBX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Primary pillar under pressure — Maintain Nasdaq listing by meeting $1.00 bid price requirement: Comparison needs review.
View ThesisRevenue is growing steadily — about 4% over the past year.
View GrowthManagement screens weak on capital allocation, margins, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 4% on a typical day and fell roughly 99% in its worst 12-month stretch.
View RiskBNBX’s bet rests on its strategic review as it shifts toward blockchain and AI infrastructure. But the company remains unprofitable, with weak recent performance and no earnings release on record. There is no valuation multiple or peer comparison available to show what the price reflects. The model puts the next-quarter miss probability near 59%. The Nasdaq listing requirement is a named risk, but its comparison needs review. Our standing thesis is on watch, and this read is provisional.
Trailing returns as of 2026-08-10. BNBX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Continue this research
Compare BNBX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BNBX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Asset Management & Custody Banks — fair value, gap to price, and forward P/E.
Compare the value case
Put BNBX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Conduct comprehensive strategic review
New strategy aligns with growth objectives and enhances competitive positioning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-08-10. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Threatens: Address Nasdaq listing compliance
Delisting threatens compliance with Nasdaq listing requirements.
Threatens: Address Nasdaq listing compliance
Delisting threatens compliance with Nasdaq listing requirements.
